Charlie Rose Program Highlights Ca Research
Martin D. Abeloff, MD, Editor-in-Chief of Oncology News International, was a recent featured guest on "The Charlie Rose Science Series" on PBS television. The episode, entitled "The Latest in Cancer Research," was the fourth in a 12-part special series focusing on the importance of scientific research in human health.
NEW YORKMartin D. Abeloff, MD, Editor-in-Chief of Oncology News International, was a recent featured guest on "The Charlie Rose Science Series" on PBS television. The episode, entitled "The Latest in Cancer Research," was the fourth in a 12-part special series focusing on the importance of scientific research in human health.
Dr. Abeloff, professor and director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, was one of a panel of four oncology thought leaders who highlighted milestones in cancer genetics and research. Other panelists included Harold Varmus, MD, president, Memorial Sloan-Kettering Cancer Center; David G. Nathan, MD, president emeritus, Dana-Farber Cancer Institute; and Deborah Schrag, MD, associate attending physician, Memorial Sloan-Kettering Cancer Center.
The Science Series is underwritten by Pfizer, Inc. Episodes 1, 2, and 3 focused on the brain, the human genome, and longevity, respectively. Sir Paul M. Nurse, PhD, president of The Rockefeller University and the 2001 Nobel Prize Laureate in Physiology or Medicine, is Mr. Rose's co-host for the series.
Video clips from past episodes in the series are posted to www.charlierose.com after airing.
MammoScreen AI Tool Improves Diagnostic Performance of Radiologists in Detecting Breast Cancer
December 16th 2020This study demonstrated that the concurrent use of this new artificial intelligence tool alongside mammography improved the diagnostic performance of radiologists in the detection of breast cancer without prolonging their workflow.
Preliminary Results Suggest AB-MR Detects Breast Cancers that 3-D Mammograms May Miss
November 29th 2020This study found that abbreviated breast magnetic resonance imaging as a supplemental screening test in women with dense breasts shows an increase in cancer detection over digital breast tomosynthesis screening.
DeepSurv Displays Possible Benefits in Prognostic Evaluation, Treatment Recommendation
July 20th 2020The deep learning survival neural network model demonstrated the potential to provide personalized treatment recommendations based on real clinical data in patients with non-small cell lung cancer.
